Newsfeeds - Spark Newswire

2 minute read

New Psychedelics ETF Launches On NYSE Arca

Today, 6:59 PM

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK) tracks the Enhanced Consciousness Index.

ATAI

3 minute read

News

Biohaven Announced Exclusive License and Research Collaboration Agreement with KU Leuven to Advance First-in-Class TRPM3 Antagonists for the Treatment of Pain; KU Leuven to Receive an Upfront Payment Plus Milestones

By Charles Gross

Today, 6:59 PM

Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.

BHVN

1 minute read

Analyst Ratings

Where Biohaven Pharma Hldgs Stands With Analysts

By Benzinga Insights

Today, 6:59 PM

Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHVN) within the last quarter:

BHVN

1 minute read

Biohaven’s Zavegepant Pain Spray Aces Late-Stage Migraine Trial

By Vandana Singh

Today, 6:59 PM

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) is eyeing filing for approval in early 2022 for its experimental pain spray after new data showed it

BHVN

3 minute read

Biohaven Reports Positive Topline Results From Pivotal Migraine Trial Of Intranasal Zavegepant Demonstrating Ultra-Rapid Pain Relief By 15 minutes; Co. Announces ‘Intranasal zavegepant 10 mg met the study’s co-primary endpoints’

By Benzinga Newsdesk

Today, 6:59 PM

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) today announced positive topline results from the second pivotal clinical trial (NCT04571060) evaluating the safety and efficacy of its investigational therapy,

BHVN

2 minute read

Biohaven, Artizan Bio Report Therapeutic Development Program In Parkinson’s Disease

By Benzinga Newsdesk

Today, 6:59 PM

Biohaven to leverage Artizan’s biobanking expertise and proprietary drug discovery engine to create Parkinson’s disease drug development program NEW HAVEN, Conn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Artizan

BHVN

1 minute read

Mizuho Maintains Buy on Biohaven Pharma Hldgs, Lowers Price Target to $135

By Benzinga Newsdesk

Today, 6:59 PM

Mizuho analyst Vamil Divan maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Buy and lowers the price target from $137 to $135.

BHVN

6 minute read

75 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:59 PM

Gainers Society Pass Incorporated (NASDAQ: SOPA) surged 436.7% to settle at $48.30 on Tuesday after the company priced its IPO at $9 per share.

ABSI

5 minute read

58 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 6:59 PM

Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash.

ABSI

1 minute read

Pfizer Gains Outside US Rights To Biohaven’s Migraine Treatment For $500M

By Vandana Singh

Today, 6:59 PM

Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN) and Pfizer Inc (NYSE:PFE) have announced an agreement for rimegepant in markets outside the U.S. Rimegepant…

BHVN